Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Amgen
Biotech
CatalYm catalyzes C-suite shake-up—Chutes & Ladders
CatalYm catalyzes C-suite shake-up. Character draws new leadership. Amgen adds top cancer scientist to research team.
Darren Incorvaia
,
Zoey Becker
Sep 19, 2025 8:30am
Amgen-Zai stomach cancer asset loses OS benefit in final analysis
Sep 3, 2025 4:33pm
Amgen looks to level up clinical trials with Veeva pact
Sep 2, 2025 3:05pm
Amgen unveils plans for $600M R&D site in California
Sep 2, 2025 11:08am
Fierce Pharma
FDA's response letter salvo sheds light on drug refusal process
Jul 11, 2025 10:15am
Amgen, Zai say stomach cancer candidate hits phase 3 mark
Jun 30, 2025 10:36am
